Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Post by jwalliscaon Nov 13, 2020 3:36pm

742 Views

Post# 31896920

Level II & Nuances Cont'd - thanks BT

Thanks for your observation BioTeck, yes, we wait for the close to complete today's activity.

Level II as of 3:33 pm EST:

Number of Shares		Bid Price
12,500 shares	12,500	0.285
60,500 shares	60,500	0.280
29,500 shares	29,500	0.275
22,000 shares	22,000	0.270
25,000 shares	25,000	0.265
35,500 shares	35,500	0.260
38,500 shares	38,500	0.255
15,000 shares	15,000	0.250
10,000 shares	10,000	0.240
10,000 shares	10,000	0.235

Level two quotes - Ask
Ask Price	Number of Shares
0.290	84,000	84,000 shares
0.295	70,500	70,500 shares
0.300	82,500	82,500 shares
0.305	500	500 shares
0.310	90,500	90,500 shares
0.315	10,500	10,500 shares
0.320	22,500	22,500 shares
0.325	10,500	10,500 shares
0.330	42,500	42,500 shares
0.335	24,500